Loading company…
Meiweida Medical develops devices for interventional oncology treatment.
Meiweida Medical develops devices for interventional oncology and intraoperative navigation. Its coaxial puncture thermocoagulation needle entered Shanghai's Class II medical device innovation channel, and its microwave ablation products are approved. Founded in 2017 and based in Shanghai, China, the company raised Series A+ funding in December 2025, led by ChuangVest Ventures with Yueli Capital and Ysun Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in